Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kaitlyn West"'
Autor:
Ramanjot Kaur, Catherine Tchanque-Fossuo, Kaitlyn West, Yasmin Hadian, Anthony Gallegos, Daniel Yoon, Ligia Ismailyan, Saul Schaefer, Sara E. Dahle, R. Rivkah Isseroff
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Abstract Background Diabetic foot ulcers (DFUs) are the most common cause of leg amputations and their management is extremely challenging. Despite many advances and expensive therapies, there has been little success in improving outcomes of DFUs. In
Externí odkaz:
https://doaj.org/article/527fab324ac34b528dd4d634fd0a3979
Autor:
Yasmin Hadian, MS, Catherine Tchanque-Fossuo, MD, Sara E. Dahle, DPM, MPH, Kaitlyn West, BS, Marat Kazak, DPM, Haines Ely, MD, Joshua M. Schulman, MD, R. Rivkah Isseroff, MD
Publikováno v:
JAAD Case Reports, Vol 6, Iss 3, Pp 201-203 (2020)
Externí odkaz:
https://doaj.org/article/480de44c2179473ab952d8304f7974f3
Autor:
Harrison Shawa, Ramanjot Kaur, Catherine Tchanque-Fossuo, Hadar Lev-Tov, Kaitlyn West, Nuen Tsang Yang, Chin-Shang Li, David M. Rocke, Sara Dahle, R. Rivkah Isseroff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b65fb01e3e299f6f03ddf06599dadabb
https://doi.org/10.2139/ssrn.4405703
https://doi.org/10.2139/ssrn.4405703
Autor:
Roslyn Rivkah Isseroff, Kaitlyn West, Daniel J. Yoon, Anthony Gallegos, Saul Schaefer, Ramanjot Kaur, Hsin-ya Yang, Catherine N. Tchanque-Fossuo, Sara E. Dahle
Publikováno v:
American Journal of Clinical Dermatology. 22:89-99
Ophthalmic timolol solution is increasingly being repurposed as a topical therapeutic for a variety of dermatologic diseases, including pyogenic granulomas, infantile hemangiomas, and chronic wounds. There are no published guidelines or protocols for
Autor:
Roslyn Rivkah Isseroff, Sara E. Dahle, Haines Ely, Yasmin Hadian, Kaitlyn West, Catherine N. Tchanque-Fossuo, Marat Kazak, Joshua M. Schulman
Publikováno v:
JAAD Case Reports, Vol 6, Iss 3, Pp 201-203 (2020)
JAAD Case Reports
JAAD Case Reports
Autor:
David M. Rocke, Hadar Lev-Tov, Kaitlyn West, Chin-Shang Li, Catherine N. Tchanque-Fossuo, Rivkah R. Isseroff, Sara E. Dahle
Publikováno v:
Journal of Tissue Engineering and Regenerative Medicine. 13:1430-1437
Healing of diabetic foot ulcers is a major challenge. Despite adhering to optimal standard of care (SOC), less than 30% of wounds heal after 20 weeks. Advanced cellular tissue-based products have shown better healing over SOC, albeit with great cost
Autor:
Daniel J, Yoon, Ramanjot, Kaur, Anthony, Gallegos, Kaitlyn, West, Hsinya, Yang, Saul, Schaefer, Catherine, Tchanque-Fossuo, Sara E, Dahle, R Rivkah, Isseroff
Publikováno v:
American journal of clinical dermatology. 22(1)
Ophthalmic timolol solution is increasingly being repurposed as a topical therapeutic for a variety of dermatologic diseases, including pyogenic granulomas, infantile hemangiomas, and chronic wounds. There are no published guidelines or protocols for
Autor:
Ligia Ismailyan, Anthony Gallegos, Daniel Yoon, Roslyn Rivkah Isseroff, Ramanjot Kaur, Sara E. Dahle, Kaitlyn West, Catherine N. Tchanque-Fossuo, Saul Schaefer, Yasmin Hadian
Publikováno v:
Trials
Trials, vol 21, iss 1
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Trials, vol 21, iss 1
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Background Diabetic foot ulcers (DFUs) are the most common cause of leg amputations and their management is extremely challenging. Despite many advances and expensive therapies, there has been little success in improving outcomes of DFUs. In prior wo
Autor:
Ramanjot Kaur, Hsin-ya Yang, Daniel Jaeho Yoon, Catherine N. Tchanque-Fossuo, Kaitlyn West, Anthony Gallegos, Roslyn Rivkah Isseroff, Sara E. Dahle, Saul Schaefer
Publikováno v:
Journal of the American Academy of Dermatology. 84(1)
Autor:
Andrew M. Wishy, Catherine N. Tchanque-Fossuo, Kaitlyn West, Sara E. Dahle, John G. Carson, David L. Dawson
Publikováno v:
Advances in Skin & Wound Care. 31:596-600
Background Diabetes mellitus is a worldwide pandemic that impacts more than 387 million people, with 29 million individuals affected in the United States alone. Diabetic patients have a 25% lifetime risk of developing a diabetic foot ulcer (DFU). Hav